Announced Sun, 19 Jul · 16:11 IST
Rossari Biotech Q1 FY27 results published in newspapers
Compliance View source PDF
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.4%1-day move
₹530.05
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.4-6.2-7.2-7.6-1.5—————
Up moveDown movePending
AI summary
Rossari Biotech published consolidated unaudited Q1 FY27 results in Financial Express and Loksatta newspapers dated July 19, 2026. Total income from operations rose to Rs 6,972 million from Rs 5,437.16 million YoY, a growth of about 28 percent. Net profit after tax grew to Rs 350.95 million from Rs 335.96 million, up about 4.5 percent. Basic EPS stood at Rs 6.34 versus Rs 6.07. Board approved results on July 18, 2026.
Likely market impact
Strong revenue growth of about 28 percent YoY but modest profit growth of 4.5 percent suggests margin pressure for shareholders to watch closely.